Skip to main content
Leadership and Administration
The Office of Research Affairs takes on bold research projects to promote scientific discovery and improve patient care at IU School of Medicine.
kellie mcdonald works at a monitor reviewing brain imaging

Research Affairs

Equipped for bold medical research and groundbreaking scientific discovery

With nearly 3,100 full-time faculty, more than $519 million in research awards and more than 645,000 square feet of dedicated research space, IU School of Medicine is well-equipped to take on bold medical research projects that promote groundbreaking scientific discovery while improving health care interventions, patient care and health outcomes.

In the most recent fiscal year, IU School of Medicine received more than $445 million in total research grants and awards, including $243 million from the National Institutes of Health. Tatiana Foroud, PhD, executive associate dean for research affairs, oversees IU School of Medicine’s research enterprise.

Meet the leadership team

Subscribe to the Research Update newsletter

Precision Health Initiative

IU School of Medicine’s Precision Health Initiative is the inaugural recipient of funding through Indiana University’s Grand Challenges Program, which will help IU School of Medicine and its partner institutions understand and optimize the prevention, onset, treatment, progression and health outcomes of human diseases through a more precise definition of the genetic, developmental, behavioral and environmental factors that contribute to an individual’s health. Developed by a team of researchers and physicians led by principal investigator Tatiana Foroud, PhD, this initiative will transform biomedical research, health care innovations and the delivery of health interventions in Indiana. The Precision Health Initiative will receive as much as $40 million in funding from the Grand Challenges Program, along with $80 million invested by IU School of Medicine.


What is the Precision Health Initiative?

The Precision Health Initiative is an ambitious plan that will cure at least one cancer through the development of new cell, gene and immune therapies and develop novel disease-modifying or prevention methods for adult neurodegenerative diseases such as Alzheimer’s Disease. It will also use gene and other therapies to cure at least one genetic pediatric disease. This initiative involves collaboration with industry and community partners, including Eli Lilly and Co., Roche Diagnostics, Cook Regentec, Deloitte, Regenstrief Institute and IU Health.

Faculty member and med student talking

Transforming Clinical Practices Initiative

IU School of Medicine is one of 29 organizations selected to receive funding as part of the $685 million Transforming Clinical Practices Initiative created by the Centers for Medicare and Medicaid in the US Department of Health and Human Services to drive changes in the practice of medicine—to help clinicians improve health and health care while lowering costs. Given four years and $46.4 million, IU School of Medicine is leading a project to support 11,500 physicians, advance practice providers and clinical pharmacists in Indiana, Illinois and Michigan.

Meet the experts

Malaz A. Boustani, MD, MPH

Richard M. Fairbanks Professor of Aging Research

Sharon M. Moe, MD

Associate Dean for Clinical and Translational Research

Medical research expertise

IU School of Medicine investigators conduct world-class basic, translational and clinical research in a broad range of scientific endeavors. Neuroscience, cancer, musculoskeletal and diabetes/cardiovascular/metabolic disorders have been designated as research priority areas and represent the school’s areas of expertise. Strategic themes within each of those priority areas are precision medicine, population health, cell-based therapy and life-span research.

Always something new

With more than $519 million in external grants and awards, IU School of Medicine oversees a comprehensive research enterprise guided by the following goals:

  • Grow research funding through focused investment
  • Recruit and retain research leaders, both physicians and research scientists
  • Enhance the health of Indiana and beyond by offering innovative therapies not available elsewhere and being a leader in population health management
  • Accelerate translation of research to the clinic and the marketplace through high-quality clinical trials and public-private partnerships
  • Train future researchers for Indiana and worldwide

Research blog

Stay current on medical research progress at IU School of Medicine by exploring and subscribing to the research blog.

Research News